Brii Biosciences (FRA:7SS) FCF Margin %: -637.46% (As of Dec. 2025)


FRA:7SS Brii Biosciences Ltd FRA:7SS
33 GF Score
Price €0.10
! 1 Warning Sign
View Full Analysis

What is Brii Biosciences FCF Margin %?

Brii Biosciences FRA:7SS -18.03% 33 FCF Margin % is -637.46% as of Dec. 2025. GuruFocus rates FRA:7SS with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Brii Biosciences ranks worse than 85.61% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Brii Biosciences's Free Cash Flow for the six months ended in Dec. 2025 was €-14.38 Mil. Brii Biosciences's Revenue for the six months ended in Dec. 2025 was €2.26 Mil. Therefore, Brii Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was -637.46%.

As of today, Brii Biosciences's current FCF Yield % is -70.62%.

The historical rank and industry rank for Brii Biosciences's FCF Margin % or its related term are showing as below:

FRA:7SS' s FCF Margin % Range Over the Past 10 Years
Min: -104293.33   Med: -2503.66   Max: -1231.1
Current: -2495.7

During the past 7 years, the highest FCF Margin % of Brii Biosciences was -1231.10%. The lowest was -104293.33%. And the median was -2503.66%.

FRA:7SS's FCF Margin % is ranked worse than
85.61% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs FRA:7SS: -2495.70

Brii Biosciences FCF Margin % Related Terms

Brii Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Brii Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brii Biosciences FCF Margin % Chart

Brii Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 -1,231.17 -104,631.65 0.00 -2,503.50

Brii Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -637.46

FRA:7SS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Brii Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brii Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brii Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Brii Biosciences's FCF Margin % falls into.


FRA:7SS
33GF Score
Brii Biosciences Ltd FRA:7SS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brii Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Brii Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-56.479/2.256
=-2,503.50 %

Brii Biosciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-14.381/2.256
=-637.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -637.46% mean?
Brii Biosciences (FRA:7SS) has a FCF Margin % of -637.46% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Brii Biosciences and its competitors. According to the industry distribution chart, Brii Biosciences ranks #821 out of 959 companies in the Biotechnology industry, placing it in the top 85.6%.
Is Brii Biosciences' FCF Margin % too high?
Brii Biosciences' current FCF Margin % is -637.46%. Based on the distribution chart, Brii Biosciences ranks #821 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Brii Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Brii Biosciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brii Biosciences ranks #821 out of 959 companies for FCF Margin %. This places Brii Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Brii Biosciences and its competitors. Brii Biosciences's current FCF Margin % is -637.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brii Biosciences stock overvalued right now?
Brii Biosciences (FRA:7SS) has a current FCF Margin % of -637.46%. The current FCF Margin % is -637.46%. Brii Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Brii Biosciences (FRA:7SS), the current FCF Margin % is -637.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brii Biosciences Business Description

Address No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and around the world. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.
33GF Score

Get the complete analysis for FRA:7SS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price